Financing channel feed – Endpoints News

Financing channel feed

With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology

8 years ago

Where the money is: Top 100 VCs investing in US biotechs during 2017

8 years ago

China biotech unicorn Innovent in talks on $200M IPO and new funding — report

8 years ago

German drugmaker files $21.6M IPO for skin cancer drug

8 years ago

Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab

8 years ago

Truffle roots for new biotechs after first close of a planned $240M fund

8 years ago

Boasting a late-stage Botox me-too, Evolus files for $75M IPO

8 years ago

Billionaire-backed Juvenescence primes the anti-aging pipeline pump with a $12M seed round

8 years ago

China's KBP Bio is coming to America, with $76M A round and GSK vet taking the helm in Philly

8 years ago

Faheem Hasnain and his ex-Receptos team launch a new biotech with $100M and a twist on the old biotech model

8 years ago

SVB's crystal ball points to big money biotech IPOs, downshift in the torrid pace of venture investing

8 years ago

Novartis backs eye drop maker in $20M round, meds to fill gap left by Eylea/Lucentis

8 years ago

BioNTech raises mammoth $270M A round, nearing $1B mark as investors continue a love affair with mRNA

8 years ago

Pfizer lines up an $830M alliance with Arvinas on protein degradation

8 years ago

All in: Boehringer Ingelheim more than doubles its venture fund to €250M

8 years ago

A better approach to growth factors? Scholar Rock raises $47M on SMA promise

8 years ago

Ex-Pfizer CEO's startup Centrexion gets $67M for PhIII painkiller

8 years ago

Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins

8 years ago

In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M

8 years ago

Following cancer combo deal with Bristol-Myers, Taris gets $25M Series B

8 years ago

Backed by Henri Termeer estate, Aura raises $30M for work to prevent blindness in eye cancer patients

8 years ago

In gene therapy's second big win this week, Orchard nabs $110M Series B

8 years ago

Flagship adds $618M in new funds to fuel startup mission

8 years ago

Parker Institute-allied Tessa grabs an $80M round for its next-gen cancer cell therapies

8 years ago

First page Previous page 132 133 134135136 137 138 Next page Last page